Disc Medicine officer proposes $1.3M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Disc Medicine, Inc. (IRON) officer William Savage reported a proposed sale of 16,035 common shares, listed at an aggregate market value of $1,303,004.10, with an approximate sale date of November 10, 2026. The listed date for plan adoption or instruction, if relying on Rule 10b5-1, is April 10, 2026.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Previously Exercised Options financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.